Table 2

Quality of life and psychological wellbeing of patients with dilated cardiomyopathy

Dilated cardiomyopathy Hypertrophic cardiomyopathy3 General population8
n601378883–9219
Physical functioning (SF-36)58.3 (24.6)2-150 60.9 (25.3)88.4 (18.0)2-150
Physical role limitations (SF-36)42.9 (38.8)2-150 55.9 (42.9)85.8 (29.9)2-150
Emotional role limitations (SF-36)67.2 (41.4)2-150 64.2 (40.7)82.9 (31.8)2-150
Social functioning (SF-36)57.0 (8.1)2-150 2-151 70.2 (26.3)2-151 88.0 (19.6)2-150
Mental health (SF-36)68.9 (21.1)2-150 65.6 (21.2)73.8 (17.2)2-150
General health perceptions (SF-36)47.0 (18.7)2-150 47.2 (24.4)73.5 (19.9)2-150
Vitality (SF-36)46.1 (22.1)2-150 43.6 (24.2)61.1 (19.7)2-150
Pain (SF-36)77.6 (19.8)2-151 66.1 (27.2)2-151 81.5 (21.7)
MOS sample9 (n = 3053)
Sleep (MOS)23.2 (6.6)2-150 28.3 (18.2)2-150
General population13 (n = 624)
Anxiety (HAD)8.10 (3.9)2-150 8.23 (4.3)4.55 (3.7)2-150
 Depression (HAD)5.17 (4.3)2-150 5.29 (3.6)3.98 (3.5)2-150

  • Values are mean (SD).

  • 3 8 9 13References of comparison samples;

  • ↵2-150 significant difference between dilated cardiomyopathy and general population comparison samples, p < 0.025;

  • ↵2-151 significant difference between dilated cardiomyopathy and hypertrophic cardiomyopathy, p < 0.003.